Rapid advances in the potency, safety, and availability of modern HIV antiretroviral therapy
(ART) have yielded a near-normal life expectancy for most people living with HIV (PLWH) …

Abstract Purpose of Review The burden of metabolic diseases, including type 2 diabetes
mellitus (T2DM), is rising among persons with HIV (PWH) on antiretroviral therapy (ART) …

Background Integrase strand transfer inhibitors (INSTIs) are associated with weight gain in
people with HIV (PWH). Less is known about the risk of other metabolic outcomes such as …

Dolutegravir is recommended for all people living with HIV because of its efficacy, high
barrier to resistance, favourable safety and tolerability profile, and affordability. Dolutegravir …

Whether integrase strand transfer inhibitors (INSTIs) are associated with a higher risk of
incident type 2 diabetes mellitus (DM) than other antiretroviral therapies (ART) needs to be …

Introduction Ageing patients with haemophilia (PWH) develop cardiovascular risk factors
impacting care. Little is known about the prevalence of diabetes in PWH and its relation to …

Objective: Recent reports of excessive weight gain in people with HIV (PWH) have raised
increasing concerns on the possible increase of diabetes mellitus (DM) risk in course of …

Aims As survival among people living with HIV (PLHIV) improves with universal HIV
treatment, new strategies are needed to support management of co‐morbidities like type 2 …

Introduction. PLHIV are thought to be more likely to develop diabetes than HIV-negative
people because of many risk factors including diabetes in the family, being overweight, age …

Background: Advancements in antiretroviral therapy (ART) have significantly improved life
expectancy, leading to an increased prevalence of older adults with HIV. This population …